1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 Tolkatchev, D. Ng, A. Vranken, W. Ni, F. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic 1 90.00 90.00 90.00 1.000 1.000 1.000 C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C3 H7 N O2 S 121.158 y CYSTEINE L-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H10 N3 O2 1 156.162 y HISTIDINE L-peptide linking C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C5 H11 N O2 S 149.211 y METHIONINE L-peptide linking C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C11 H12 N2 O2 204.225 y TRYPTOPHAN L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking US Biochemistry BICHAW 0033 0006-2960 39 2878 2886 10.1021/bi992130u 10715107 Design and solution structure of a well-folded stack of two beta-hairpins based on the amino-terminal fragment of human granulin A. 2000 10.2210/pdb1g26/pdb pdb_00001g26 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 3393.955 GRANULIN A N-TERMINAL DOMAIN (RESIDUES 1-31) D1V, K3H, S9I, Q20P 1 syn polymer HGA no no VVHCDMEVICPDGYTCCRLPSGAWGCCPFTQ VVHCDMEVICPDGYTCCRLPSGAWGCCPFTQ A polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n database_2 pdbx_nmr_spectrometer pdbx_struct_assembly pdbx_struct_oper_list struct_ref_seq_dif repository Initial release Version format compliance Version format compliance Data collection Database references Derived calculations 1 0 2000-11-01 1 1 2008-04-27 1 2 2011-07-13 1 3 2021-11-03 _database_2.pdbx_DOI _database_2.pdbx_database_accession _pdbx_nmr_spectrometer.model _struct_ref_seq_dif.details 1QGM belongs to a family of granulin-like repeats 1FWO belongs to a family of granulin-like repeats RCSB Y RCSB 2000-10-17 REL REL The peptide was chemically synthesized using standard Fmoc chemistry and oxidized by air in solution, Cys17 and Cys27 were blocked with S-acetamidomethyl groups (Acm) sample This structure was determined using standard 2D homonuclear techniques structures with the least restraint violations 200 10 2D NOESY 2D NOESY 2D NOESY 2D NOESY 5.0 ambient 288 K 5.0 ambient 298 K The structures are based on a total of 241 restraints, 174 are unambiguous NOE-derived distance constraints, 47 ambiguous NOE-derived distance constraints, 8 dihedral angle restraints, 10 distance restraints from hydrogen bonds, 2 distance restraints from disulfide bonds. distance geometry and simulated annealing 0.5 mM HGA 1-31 (D1V, K3H, S9I, Q20P); 20 mM sodium acetate-d3, 10% D2O, 90% H2O 10% D2O, 90% H2O 0.5 mM HGA 1-31 (D1V, K3H, S9I, Q20P); 20 mM sodium acetate-d3, 100% D2O 100% D2O Brunger refinement X-PLOR 3.1 Brunger structure solution X-PLOR 3.1 500 Bruker AVANCE 500 Bruker DRX VAL 1 n 1 VAL 1 A VAL 2 n 2 VAL 2 A HIS 3 n 3 HIS 3 A CYS 4 n 4 CYS 4 A ASP 5 n 5 ASP 5 A MET 6 n 6 MET 6 A GLU 7 n 7 GLU 7 A VAL 8 n 8 VAL 8 A ILE 9 n 9 ILE 9 A CYS 10 n 10 CYS 10 A PRO 11 n 11 PRO 11 A ASP 12 n 12 ASP 12 A GLY 13 n 13 GLY 13 A TYR 14 n 14 TYR 14 A THR 15 n 15 THR 15 A CYS 16 n 16 CYS 16 A CYS 17 n 17 CYS 17 A ARG 18 n 18 ARG 18 A LEU 19 n 19 LEU 19 A PRO 20 n 20 PRO 20 A SER 21 n 21 SER 21 A GLY 22 n 22 GLY 22 A ALA 23 n 23 ALA 23 A TRP 24 n 24 TRP 24 A GLY 25 n 25 GLY 25 A CYS 26 n 26 CYS 26 A CYS 27 n 27 CYS 27 A PRO 28 n 28 PRO 28 A PHE 29 n 29 PHE 29 A THR 30 n 30 THR 30 A GLN 31 n 31 GLN 31 A author_defined_assembly 1 monomeric 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 identity operation 0.0000000000 0.0000000000 0.0000000000 A N ASP 5 A N ASP 5 A O VAL 8 A O VAL 8 A O CYS 17 A O CYS 17 A N GLY 25 A N GLY 25 1 A A O H PRO TYR 11 14 1.56 3 A A O H PRO GLY 11 13 1.56 5 A A O H PRO GLY 11 13 1.55 6 A A O H PRO GLY 11 13 1.55 8 A A H O VAL CYS 2 10 1.59 10 A A O H PRO GLY 11 13 1.57 1 A ARG 18 0.275 SIDE CHAIN 2 A ARG 18 0.205 SIDE CHAIN 3 A ARG 18 0.181 SIDE CHAIN 4 A ARG 18 0.317 SIDE CHAIN 5 A ARG 18 0.285 SIDE CHAIN 6 A ARG 18 0.260 SIDE CHAIN 7 A ARG 18 0.180 SIDE CHAIN 8 A ARG 18 0.235 SIDE CHAIN 9 A ARG 18 0.262 SIDE CHAIN 10 A ARG 18 0.282 SIDE CHAIN 1 A HIS 3 -51.59 89.77 1 A ASP 5 177.90 -170.79 2 A VAL 8 -167.19 119.62 2 A ASP 12 54.12 -77.57 3 A HIS 3 -46.05 106.67 3 A ASP 5 -156.87 -139.71 3 A PRO 11 -81.15 41.06 3 A ASP 12 66.34 -57.97 3 A PHE 29 -147.63 59.84 3 A THR 30 -116.18 69.92 4 A ASP 5 -168.88 -166.45 4 A SER 21 -99.14 31.66 5 A HIS 3 -59.07 82.32 5 A GLU 7 -136.61 -33.16 5 A PRO 11 -80.33 38.01 5 A ASP 12 66.32 -56.33 5 A PHE 29 -147.66 -45.42 6 A ASP 5 -169.54 -80.08 6 A MET 6 -146.15 -53.79 6 A PRO 11 -78.59 43.14 6 A ASP 12 65.05 -58.95 7 A HIS 3 56.07 93.50 7 A ASP 5 -163.40 -153.61 7 A PRO 11 -80.25 38.84 7 A ASP 12 66.69 138.19 7 A PHE 29 -153.60 20.56 8 A ASP 5 -145.46 -147.27 8 A ASP 12 -48.86 -19.16 8 A PRO 20 -80.01 41.58 8 A SER 21 -168.33 30.05 8 A THR 30 -143.26 37.65 9 A ASP 5 -160.18 -134.10 9 A GLU 7 -121.83 -60.92 9 A PRO 11 -78.98 42.77 9 A ASP 12 63.04 137.91 9 A PHE 29 -158.53 53.74 10 A VAL 2 -104.40 56.07 10 A ASP 5 -146.54 -60.61 10 A MET 6 -176.51 -36.03 10 A PRO 11 -82.09 32.98 10 A ASP 12 66.59 -56.31 THE SOLUTION STRUCTURE OF A WELL-FOLDED PEPTIDE BASED ON THE 31-RESIDUE AMINO-TERMINAL SUBDOMAIN OF HUMAN GRANULIN A 1 N N disulf 2.019 A CYS 4 A SG CYS 4 1_555 A CYS 16 A SG CYS 16 1_555 disulf 2.020 A CYS 10 A SG CYS 10 1_555 A CYS 26 A SG CYS 26 1_555 CYTOKINE granulin/epithelin protein repeats, beta-hairpin stack, CYTOKINE GRN_HUMAN UNP 1 281 P28799 MWTLVSWVALTAGLVAGTRCPDGQFCPVACCLDPGGASYSCCRPLLDKWPTTLSRHLGGPCQVDAHCSAGHSCIFTVSGT SSCCPFPEAVACGDGHHCCPRGFHCSADGRSCFQRSGNNSVGAIQCPDSQFECPDFSTCCVMVDGSWGCCPMPQASCCED RVHCCPHGAFCDLVHTRCITPTGTHPLAKKLPAQRTNRAVALSSSVMCPDARSRCPDGSTCCELPSGKYGCCPMPNATCC SDHLHCCPQDTVCDLIQSKCLSKENATTDLLTKLPAHTVGDVKCDMEVSCPDGYTCCRLQSGAWGCCPFTQAVCCEDHIH CCPAGFTCDTQKGTCEQGPHQVPWMEKAPAHLSLPDPQALKRDVPCDNVSSCPSSDTCCQLTSGEWGCCPIPEAVCCSDH QHCCPQGYTCVAEGQCQRGSEIVAGLEKMPARRASLSHPRDIGCDQHTSCPVGGTCCPSLGGSWACCQLPHAVCCEDRQH CCPAGYTCNVKARSCEKEVVSAQPATFLARSPHVGVKDVECGEGHFCHDNQTCCRDNRQGWACCPYRQGVCCADRRHCCP AGFRCAARGTKCLRREAPRWDAPLRDPALRQLL 281 311 1G26 1 31 P28799 A 1 1 31 1 ASP engineered mutation VAL 1 1G26 A P28799 UNP 281 1 1 LYS engineered mutation HIS 3 1G26 A P28799 UNP 283 3 1 SER engineered mutation ILE 9 1G26 A P28799 UNP 289 9 1 GLN engineered mutation PRO 20 1G26 A P28799 UNP 300 20 2 2 anti-parallel anti-parallel A VAL 2 A VAL 2 A ASP 5 A ASP 5 A VAL 8 A VAL 8 A CYS 10 A CYS 10 A TYR 14 A TYR 14 A ARG 18 A ARG 18 A TRP 24 A TRP 24 A PRO 28 A PRO 28 1 P 1